InMode (INMD) Gains from Investment Securities (2019 - 2025)
InMode (INMD) posted quarterly Gains from Investment Securities of $1000.0 for Q4 2025, up 133.33% year-on-year from $428.57 in Q4 2024, and down 90.91% on a QoQ basis from $11000.0 in Q3 2025.
InMode (INMD) Gains from Investment Securities (2019 - 2025) Analysis & Trends
InMode (INMD) has reported Gains from Investment Securities for 6 consecutive years, with $1000.0 the latest figure, recorded in Q4 2025.
- Quarterly Gains from Investment Securities rose 133.33% year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14000.0 (down 91.62% YoY) and the FY2025 annual result came in at $15000.0, down 91.02% from the prior year.
- Gains from Investment Securities fell to $1000.0 in Q4 2025 per INMD's latest filing, from $11000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for INMD reached as high as $142000.0 in Q4 2021 and fell as low as -$3000.0 in Q4 2024.
- A 4-year average of $28666.7 and a median of $14000.0 in 2022 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities surged 4633.33% — and 2025, when it slumped 95.54%.
- Year by year, Gains from Investment Securities stood at $142000.0 in 2021, then sank by 84.51% to $22000.0 in 2022, then sank by 113.64% to -$3000.0 in 2024, then soared by 133.33% to $1000.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $1000.0, $11000.0, and $5000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | InMode | 978,911.41 | -479.15 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 23,000.00 |